An Imported Pain Gel Promises Instant Relief. Here's What It Actually Delivers.

Consumer Reports  ·  Topical Analgesics

QuickRelief, a herbal topical from Japan, is gaining shelf space at U.S. wellness retailers as shoppers grow wary of pills. Our two-week review looked at the chemistry, the claims, and the limits.

QuickRelief gel
Photo A tube of QuickRelief gel, the Japanese-made topical now stocked by several U.S. independent pharmacies and online wellness retailers. Lindsey Tong / The Health Observer

At a small kusuri shop in the western suburbs, a pharmacist squeezed a pea-size dab of green gel onto the back of her hand. Within seconds the spot felt cold, then — about a minute later — distinctly warm. The product, called QuickRelief, is one of a new class of herbal topical analgesics quietly migrating from Japanese drugstores onto the shelves of American wellness retailers, and into the medicine cabinets of consumers who say they want relief without reaching for a pill.

Search interest for the brand on U.S. e-commerce platforms has roughly tripled since January, according to data shared with The Health Observer by a third-party retail analytics firm. Independent pharmacies in New York, Los Angeles and the San Francisco Bay Area now stock it alongside more established names like Tiger Balm and Salonpas.

Unlike oral pain relievers, QuickRelief is a localized, non-pharmaceutical product. Its manufacturer says the formula contains no synthetic steroids, no methyl salicylate — the active compound in many traditional pain rubs — and none of the more common allergens. Several users interviewed for this review reported a noticeable cooling sensation within roughly 90 seconds of application, transitioning to a gentle warmth over the next few minutes.

The Chemistry: Why Menthol and Camphor

According to the ingredient label, the gel's active compounds are menthol, camphor, and eucalyptus leaf oil. The first two act on the skin's TRPM8 and TRPV1 receptors, producing what neuroscientists sometimes call a "thermal illusion" — cool and warm signals that compete with, and partially mask, the brain's perception of pain. Eucalyptus oil contributes mild anti-inflammatory effects and surface-level vasodilation.

Herbal ingredients
Figure 1 The product's active ingredients are familiar to anyone who has used a traditional pain rub. What's new is the lightweight, fast-absorbing gel format.

Dr. Soichi Yamamoto, an osteopath at a Tokyo clinic who agreed to comment on the product category — though not the brand specifically — said this style of topical has been a quiet staple of Japanese pharmacies for decades. "What's changed," he said, "is the format. These newer gels are lighter, less greasy, and easier to carry. They aren't medicine. They're a daily tool for taking the edge off."

They aren't medicine. They're a daily tool for taking the edge off. Consumers need to understand that distinction.
— Dr. Soichi Yamamoto  ·  Osteopath, Tokyo

What the Reporting Found

For this review, The Health Observer asked six volunteers — three office workers, two recreational athletes, and a retired schoolteacher with chronic shoulder pain — to use the gel daily for seven days. All six reported a cooling sensation between one and two minutes after application, transitioning to warmth at the six-to-nine minute mark. The warming phase lasted, on average, 40 to 55 minutes.

By the Numbers — Seven-Day Trial
6
Volunteers tracked across the trial
90sec
Median time to first cooling sensation
48min
Average duration of warming phase
4/6
Volunteers who would keep using it
2/6
Reported "limited" effect on joint pain
0
Adverse skin reactions reported
Source: The Health Observer reader trial · April 28 — May 4, 2026
Application of gel
Figure 2 Skin-surface temperature follows a two-phase curve — first cooling, then warming — consistent with the menthol-camphor mechanism.

By the seventh day, four of the six said they would continue using it. The remaining two — both with longer-running issues, including one case of mild knee osteoarthritis — described the relief as "noticeable but limited." Notably, the manufacturer does not advertise the product as a treatment for structural joint conditions.

What It Is Not

Any topical containing menthol and camphor carries the usual cautions. It should not be applied to broken skin, the face, children under three, or by pregnant women without medical guidance. A small number of testers in our trial reported brief redness on more sensitive areas of skin; the reaction subsided on its own within an hour.

QuickRelief lists these warnings in both English and Japanese on its packaging, but during visits to four U.S. retailers, this reporter observed that store staff did not always volunteer them. Shoppers, particularly those used to OTC pills, should read the label.

The Bigger Shift

In a country increasingly cautious about over-the-counter painkillers — a caution shaped, in part, by two decades of opioid-related public health reporting — topical, non-pharmaceutical products are getting a second look. QuickRelief isn't a breakthrough. But it does sit at an interesting intersection: between the wellness shelf and the medicine cabinet, between something you treat yourself with and something a doctor prescribes.

That distinction matters. As more products in this category arrive in the U.S. market, the question for shoppers isn't whether the marketing sounds appealing. It's whether three things are true: the ingredients are disclosed in full, the warnings are clear, and the product doesn't pretend to be something it isn't. When all three hold up, a tube of gel earns its place in the bag.

Editor's Note This article is part of The Health Observer's independent Consumer Reports series. It is not medical advice. Readers managing chronic pain or taking prescription medication should consult a clinician before adding any topical product to their routine. Reader correspondence: desk@healthobserver.com
End of article
LT

Lindsey Tong

Lindsey Tong is a staff reporter on the Health Desk, covering consumer health products, wellness markets, and the regulatory questions in between. She joined The Health Observer in 2022 after five years at a national medical publication.

In Stock · Ships Today Shop QuickRelief™